Skip to main content
Log in

Morbus Parkinson: Klinik, Differenzialdiagnostik und Therapie. Von Priv.-Doz. Dr. med. Carsten Buhmann, Universitätsklinikum Eppendorf, Hamburg

  • Originalarbeit
  • Published:
focus neurogeriatrie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Zitate und weiterführende Literatur

  • Arnold G, Tatsch K, Oertel WH et al. Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI. J Neural Transm Suppl 1994; 42: 111–118

    PubMed  CAS  Google Scholar 

  • Benamer TS, Patterson J, Grosset DG et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000; 15: 503–510

    Article  PubMed  CAS  Google Scholar 

  • Berg D, Becker G, Zeiler B et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53: 1026–1031

    PubMed  CAS  Google Scholar 

  • Braak H, Braak E. Pathoanatomy of Parkinson's disease. Journal of Neurology 2000; 247: 3–10

    Article  Google Scholar 

  • Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002; 249 Suppl 3: III/1–III/5

    Google Scholar 

  • Buck A, Westera G, Sutter M, Albani C, Kung HF, von Schulthess GK. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases. J Nucl Med 1995; 36: 1196–1200

    PubMed  CAS  Google Scholar 

  • Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004; 19: 1175–1182

    Article  PubMed  Google Scholar 

  • Comella CL. Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 2003; 3: 173–180

    Article  PubMed  Google Scholar 

  • Csoti I, Warmuth-Metz M, Solymosi L, Becker DG, Fornadi F, Naumann M. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography]. Nervenarzt 2004; 75: 128–134

    Article  PubMed  CAS  Google Scholar 

  • Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149: 443–454

    PubMed  CAS  Google Scholar 

  • de Rijk MC, Launer LJ, Berger K et al. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: 21–23

    Google Scholar 

  • Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896–908

    Article  PubMed  CAS  Google Scholar 

  • Diener and HC et al. Leitlinien der Deutschen Gesellschaft für Neurologie. Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag 2005; 48–71

  • Eggert K, Odin P, Gasser T, Meinertz T, Strasser R, Osterspey A, Deuschl G, Oertel and W. Deutsches Ärzteblatt 2005;1-2: 102, A-30 / B-22 / C-20

  • El Sharkawi A, Ramig L, Logemann JA et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry 2002; 72: 31–36

    Article  PubMed  CAS  Google Scholar 

  • Ellis T, de Goede CJ, Feldman RG, Wolters EC, Kwakkel G, Wagenaar RC. Efficacy of a physical therapy program in patients with Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil 2005; 86: 626–632

    Article  PubMed  Google Scholar 

  • Emre M, Aarsland D, Albanese A et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004; 351: 2509–2518

    Article  PubMed  CAS  Google Scholar 

  • Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 1988; 51: 745–752

    CAS  Google Scholar 

  • Gilman S, Low PA, Quinn N et al. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 1998; 74: 189–192

    PubMed  CAS  Google Scholar 

  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442

    Article  PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinico-pathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140–148

    PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992a; 55: 181–184

    PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 1992b; 55: 181–184

    PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57: 1497–1499

    PubMed  CAS  Google Scholar 

  • Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol 2000; 57: 369–372

    Article  PubMed  CAS  Google Scholar 

  • Jöbges M, Heuschkel G, Pretzel C, Illhardt C, Renner C, Hummelsheim H. Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1682–1687

    Article  PubMed  Google Scholar 

  • Langston JW. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann Neurol 1998; 44: S45–S52

    Article  PubMed  CAS  Google Scholar 

  • Litvan I, Agid Y, Calne D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Marti-Masso JF, Poza JJ, Lopez dM. Drugs inducing or aggravating parkinsonism: a review. Therapie 1996; 51: 568–577

    PubMed  CAS  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–1124

    PubMed  CAS  Google Scholar 

  • Nieuwboer A, Kwakkel G, Rochester L et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007; 78: 134–140

    Article  PubMed  CAS  Google Scholar 

  • Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The Parkinson Study Group. N Engl J Med 1999; 340: 757–763

    Article  Google Scholar 

  • Plotkin M, Amthauer H, Klaffke S et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 2005; 112: 677–692

    Article  PubMed  CAS  Google Scholar 

  • Przuntek H, Muller T, Riederer P. Diagnostic staging of Parkinson's disease: conceptual aspects. J Neural Transm 2004; 111: 201–216

    Article  PubMed  CAS  Google Scholar 

  • Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord. 2001; 16: 79–83

    Article  PubMed  CAS  Google Scholar 

  • Schapira AH. Pathogenesis of Parkinson's disease. Baillieres Clin Neurol 1997; 6: 15–36

    PubMed  CAS  Google Scholar 

  • Schrag A, Ben Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002; 73: 529–534

    Article  PubMed  CAS  Google Scholar 

  • Schrag A, Good CD, Miszkiel K et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697–702

    PubMed  CAS  Google Scholar 

  • Schrag A, Kingsley D, Phatouros C et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998; 65: 65–71

    Article  PubMed  CAS  Google Scholar 

  • Schuurman AG, van den AM, Ensinck KT et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 2002; 58: 1501–1504

    PubMed  CAS  Google Scholar 

  • Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord. 2004; 19: 1445–1449

    Article  PubMed  Google Scholar 

  • Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003; 60: 74–77

    Article  PubMed  CAS  Google Scholar 

  • Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002; 109: 191–196

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buhmann, C. Morbus Parkinson: Klinik, Differenzialdiagnostik und Therapie. Von Priv.-Doz. Dr. med. Carsten Buhmann, Universitätsklinikum Eppendorf, Hamburg. focus neurogeriatrie 1, 33–39 (2007). https://doi.org/10.1007/s12151-008-0079-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12151-008-0079-9

Navigation